Detalhe da pesquisa
1.
Mpox infection protects against re-challenge in rhesus macaques.
Cell
; 186(21): 4652-4661.e13, 2023 10 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37734373
2.
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike.
Cell
; 184(19): 4969-4980.e15, 2021 09 16.
Artigo
Inglês
| MEDLINE | ID: mdl-34332650
3.
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.
Cell
; 184(12): 3205-3221.e24, 2021 06 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34015271
4.
Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques.
Cell
; 183(1): 185-196.e14, 2020 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33007262
5.
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production.
Cell
; 183(6): 1496-1507.e16, 2020 12 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33171099
6.
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody.
Cell
; 180(3): 471-489.e22, 2020 02 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32004464
7.
Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses.
Cell
; 173(7): 1783-1795.e14, 2018 06 14.
Artigo
Inglês
| MEDLINE | ID: mdl-29731169
8.
Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo.
Cell
; 170(4): 637-648.e10, 2017 Aug 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28757252
9.
Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency.
Cell
; 165(7): 1609-1620, 2016 Jun 16.
Artigo
Inglês
| MEDLINE | ID: mdl-27315478
10.
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity.
Cell
; 165(7): 1621-1631, 2016 Jun 16.
Artigo
Inglês
| MEDLINE | ID: mdl-27315479
11.
Intra-spike crosslinking overcomes antibody evasion by HIV-1.
Cell
; 160(3): 433-46, 2015 Jan 29.
Artigo
Inglês
| MEDLINE | ID: mdl-25635457
12.
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice.
Cell
; 161(7): 1505-15, 2015 Jun 18.
Artigo
Inglês
| MEDLINE | ID: mdl-26091035
13.
Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity.
Cell
; 158(6): 1243-1253, 2014 Sep 11.
Artigo
Inglês
| MEDLINE | ID: mdl-25215485
14.
Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice.
Cell
; 158(5): 989-999, 2014 Aug 28.
Artigo
Inglês
| MEDLINE | ID: mdl-25131989
15.
Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope.
Immunity
; 50(6): 1513-1529.e9, 2019 06 18.
Artigo
Inglês
| MEDLINE | ID: mdl-31126879
16.
Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization.
Cell
; 153(1): 126-38, 2013 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-23540694
17.
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys.
Cell
; 155(3): 531-9, 2013 Oct 24.
Artigo
Inglês
| MEDLINE | ID: mdl-24243013
18.
Prolonged viral suppression with anti-HIV-1 antibody therapy.
Nature
; 606(7913): 368-374, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35418681
19.
Combination anti-HIV antibodies provide sustained virological suppression.
Nature
; 606(7913): 375-381, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35650437
20.
Indoline CD4-mimetic compounds mediate potent and broad HIV-1 inhibition and sensitization to antibody-dependent cellular cytotoxicity.
Proc Natl Acad Sci U S A
; 120(13): e2222073120, 2023 03 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36961924